Advertisement

Cardiovascular Complications in Uremia and Dialysis

  • Miroslaw Smogorzewski

Abstract

Cardiovascular complications occur frequently in patients with renal disease and are the leading cause of death in patients with end-stage renal disease (ESRD). Cardiac disease accounted for 39% of all deaths in dialysis patients between 1988 and 1990 in the U.S. (1), 37.8% of deaths in Canada (2), and up to 30% in Europe (3). U.S. Renal Data Systems (USRDS) classifies cardiac diseases as a cause of death into three categories: myocardial infarction, pericarditis, and other cardiac causes, with a death rate of 19.9, 1, and 42.4 per 1000 patients per year, respectively, during the period 1988–1990. The category other cardiac causes includes congestive heart failure, subacute and chronic ischemic heart disease, cardiomyopathy, arrhythmias, and valvular disease. For all patients between 45 and 65 years of age on dialysis, the death rate from cardiovascular disease was approximately 3.5 times the age-specific rate for the normal population (4).

Keywords

Chronic Renal Failure Infective Endocarditis Dialysis Patient Pericardial Effusion Cardiac Tamponade 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. U.S. Renal Data Systems: USRDS 1993 Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD, pp 4954, 1993.Google Scholar
  2. 2.
    Canadian Organ Replacement Register: 1991 Annual Report. Hospital Medical Records Institute, Don Mills, Ontario, Canada, April 1993.Google Scholar
  3. 3.
    European Dialysis and Transplant Association: Annual Report on Regular Dialysis and Transplantation in Europe XXII,1991.Google Scholar
  4. 4.
    Greaves SC, Sharpe DN: Cardiovascular disease in patients with end-stage renal failure. Aust NZ J Med 22: 153–159, 1992.CrossRefGoogle Scholar
  5. 5.
    Foley RN, Parfrey PS, Hefferton D, Singh I, Simons A, Brendan J, Barrett MB: Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 23: 836–845, 1994.PubMedGoogle Scholar
  6. 6.
    Kennel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241: 2035–2038, 1979.CrossRefGoogle Scholar
  7. 7.
    Braun WE, Phillips DF, Vidt DG, et al.: Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16: 603–607, 1984.PubMedGoogle Scholar
  8. 8.
    Philipson JD, Carpenter BJ, Itzkoff J, et al.: Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81: 630–634, 1986.PubMedCrossRefGoogle Scholar
  9. 9.
    Bennett WM, Kloster F, Rosch J, Barry J, Porter CA: Natural history of asymptomatic coronary angiographic lesions in diabetic patients with end-stage renal disease. Am J Med 65: 779, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Massie BM, Tubau TF, Szlachcic J, et al.: Hypertensive heart disease: the critical role of left ventricular hypertrophy. J Cardiovasc Pharmacol 13 (Suppl 1): 518–524, 1989.Google Scholar
  11. 11.
    Kannel WB: Role of blood pressure in cardiovascular disease: The Framingham Study. Angiology 26: 1–14, 1975.PubMedCrossRefGoogle Scholar
  12. 12.
    Mac Mahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbot FR, Godwin J, Dyer A, Stamler J: Blood pressure, stroke and coronary heart disease. Lancet 335: 765–774, 1990.CrossRefGoogle Scholar
  13. 13.
    Haire HM, Sherrand DJ, Scandapane D, et al.: Smoking, hypertension and mortality in a maintenance dialysis population. Cardiovasc Med 3: 1163–1168, 1978.Google Scholar
  14. 14.
    Ayus JC, Frommer P, Olivero JJ, et al.: Effect of long-term dialysis on left ventricular ejection fraction in end-stage renal disease. Kidney Int 19: 142A, 1981.Google Scholar
  15. 15.
    de-Leeuw PW: Pathophysiology of hypertension in patients on renal replacement therapy. Blood Purif 12: 245–251, 1994.PubMedCrossRefGoogle Scholar
  16. 16.
    Neff MS, Kim KE, Persoff M, Onesti G, Swartz C: Hemodynamics of uremic anemia. Circulation 63: 876–883, 1971.CrossRefGoogle Scholar
  17. 17.
    Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912 1918, 1992.Google Scholar
  18. 18.
    London GM, Zins B, Pannier B, Naret C, Berthelot M, Jacquot C, Safar M, Drueke TB: Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 36: 878–882, 1989.PubMedCrossRefGoogle Scholar
  19. 19.
    Satoh K, Masuda T, Ikeda Y, Kurokawa S, Kamata K, Kikawada R, Takamoto T, Marumo F: Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients. Hypertension 15: 262–266, 1990.PubMedCrossRefGoogle Scholar
  20. 20.
    Martinez-Vea A, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA: Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis 19: 353–357, 1992.PubMedGoogle Scholar
  21. 21.
    Fellner SK, Lang RM, Neumann A, Korcarz C, Borow KM: Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int 44: 1309–1315, 1993.PubMedCrossRefGoogle Scholar
  22. 22.
    Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis is prolonged maintenance hemodialysis. N Engl J Med 290: 697–701, 1974.PubMedCrossRefGoogle Scholar
  23. 23.
    Attman PO, Alaupovic P: Lipid abnormalities in chronic renal insufficiency. Kidney Int 39: 516–523, 1991.Google Scholar
  24. 24.
    Bloembergen WE, Port FK, Mauger EA, Wolfe RA: Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol 5: 1231–1242, 1994.PubMedGoogle Scholar
  25. 25.
    Silins J, Fortier L, Mao Y, et al.: Mortality rates among patients with end-stage renal disease in Canada, 1981–1986. Can Med Assoc J 141: 677–682, 1989.Google Scholar
  26. 26.
    Massry SG, Smogorzewski M, Perne AF: Parathyroid hormone and myocardiopathy of chronic renal failure. In PS Parfrey, JD Harnett, eds, Cardiac Dysfunction in Chronic Uremia. Kluwer Academic Publishers, Boston, pp 139–160, 1992.CrossRefGoogle Scholar
  27. 27.
    Parfrey PS, Harnett JD, Griffiths S, Gualt MH, Barre PE, Guttman RD: Low-output left ventricular failure in end-stage renal disease. Am J Nephrol 7: 184–191, 1987.PubMedCrossRefGoogle Scholar
  28. 28.
    London GM, Fabiani F, Marchais SJ, De Vernejoul M Ch, Guerin A, Safar ME, Metivier F, Llach F: Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 31: 973–980, 1987.PubMedCrossRefGoogle Scholar
  29. 29.
    Drueke T, Fauchet M, Fleury J, Lesourd P, Toure V, LePailleur C, de-Vernejoul P, Crosnier J: Effect of parathyroidectomy on left ventricular function in haemodialysis patients. Lancet 1: 112–114, 1980.PubMedCrossRefGoogle Scholar
  30. 30.
    Smogorzewski M, Zayed M, Zhang Y-B, Roe J, Massry SG: Parathyroid hormone increases cytosolic calcium concentra-Google Scholar
  31. tion in adult rat cardiac myocytes. Am J Physicol 264: H1998–H2006, 1993.Google Scholar
  32. 31.
    Zhang Y-B, Smogorzewski M, Ni Z, Massry SG: Altered cytosolic calcium Homeostasis in rat cardiac myocytes in CRF. Kidney Int 45: 1113–1119, 1994.PubMedCrossRefGoogle Scholar
  33. 32.
    Smogorzewski M, Tian J, Massry SG: Downregulation of PTH-PTHrP receptor of the heart in CRF: role of [Cali. Kidney Int 47: 1182–1186, 1995.PubMedCrossRefGoogle Scholar
  34. 33.
    Perna AF, Smogorzewski M, Massry SG: Effect of verapamil on the abnormalities in fatty acid oxidation of myocardium. Kidney Int 36: 453–457, 1989.PubMedCrossRefGoogle Scholar
  35. 34.
    Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role of parathroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4: 1814–1819, 1994.PubMedGoogle Scholar
  36. 35.
    Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocytic fibrosis in uremic patients. Nephrol Dial Transplant 5: 39–44, 1990.PubMedCrossRefGoogle Scholar
  37. 36.
    Freeman GL, LeWinter MM: Pericardial adaptations during cardiac dilatation in dogs. Circ Res 54: 294–300, 1984.PubMedCrossRefGoogle Scholar
  38. 37.
    Wacker W, Merill JP: Uremic pericarditis in acute and chronic renal failure. JAMA 156: 764–765, 1954.CrossRefGoogle Scholar
  39. 38.
    Bailey GL, Hampers CL, Hager EB, Merrill JP: Uremic pericarditis: clinical features and management. Circulation 38: 582–591, 1968.PubMedCrossRefGoogle Scholar
  40. 39.
    Compty CM, Cohen SL, Shapiro FL: Pericarditis in chronic uremia and its sequels. Ann Intern Med 75: 173–183, 1971.CrossRefGoogle Scholar
  41. 40.
    Ribot S, Frankel JH, Gielchincky I, et al.: Treatment of uremic pericarditis. Clin Nephrol 2: 127–130, 1974.PubMedGoogle Scholar
  42. 41.
    Wray TM, Stone WJ: Uremic pericarditis: a prospective echocardiographic and clinical study. Clin Nephrol 6: 295302, 1976.Google Scholar
  43. 42.
    Frommer JP, Young JB, Ayus JC: Asymptomatic pericardial effusion in uremic patients: effect of long-term dialysis. Nephron 39: 296–301, 1985.PubMedCrossRefGoogle Scholar
  44. 43.
    Rutsky EA, Rostand SG: Treatment of uremic pericarditis and pericardial effusion. Am J Kidney Dis 10: 2–8, 1987.PubMedGoogle Scholar
  45. 44.
    Rostand SG, Rutsky EA: Pericarditis in end-stage renal disease. Cardiol Clin 8: 701–707, 1990.PubMedGoogle Scholar
  46. 45.
    Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 16: 31–36, 1993.PubMedGoogle Scholar
  47. 46.
    Renfrew RM, Buselmeier TJ, Kjellstrand CM: Pericarditis and renal failure. Annu Rev Med 31: 345–360, 1980.PubMedCrossRefGoogle Scholar
  48. 47.
    Silverberg S, Oreopoulos DG, Wise DJ, et al.: Pericarditis in patients undergoing long-term hemodialysis and peritoneal dialysis. Incidence, complications and management. Am J Med 63: 874–880, 1977.PubMedCrossRefGoogle Scholar
  49. 48.
    Young JB, Frommer P, Ayus JC, Alexander JK, Miller RR: Effect of dialysis on pericardial effusion: a prospective echocardiographic study in end-stage renal failure patients. Circulation 62: 111–186, 1980.Google Scholar
  50. 49.
    Drueke T, LePailleur C, Zingraff J, Jungers P: Uremic cardiomyopathy and pericarditis. Adv Nephrol Necker Hosp 9: 33–70, 1980.PubMedGoogle Scholar
  51. 50.
    Osanloo E, Shalhoub RJ, Cioffi RF, Parker RH: Viral pericarditis in patients receiving hemodialysis. Arch Intern Med 139: 301–303, 1979.PubMedCrossRefGoogle Scholar
  52. 51.
    Joffe P, Johannessen AC: Uremic pericarditis, an epidemic disease. Danish Med Bull 34: 117–118, 1987.PubMedGoogle Scholar
  53. 52.
    Sever MS, Steinmuller DR, Hayes JM, Steem SB, Novick AC: Pericarditis following renal transplantation. Transplantation 51:1229–1232, 1991.Google Scholar
  54. 53.
    Twardowski ZJ, Alpert MA, Gupta RC, Nolph KD, Madsen BT: Circulating immune complexes: possible toxins responsible for serositis (pericarditis, pleuritis, and peritonitis) in renal failure. Nephron 35: 190–195, 1983.PubMedCrossRefGoogle Scholar
  55. 54.
    Maisch B, Kochsiek K: Humoral immune reactions in uremic pericarditis. Am J Nephrol 3: 264–271, 1983.PubMedCrossRefGoogle Scholar
  56. 55.
    De Pace NL, Nestico PF, Schwartz AB, et al.: Predicting success of intensive dialysis in the treatment of uremic patients. Am J Med 76: 38–46, 1984.PubMedCrossRefGoogle Scholar
  57. 56.
    Engel PJ: Echocardiographic findings in pericardial disease. In: NO Fowler, ed, The Pericardium in Health and Disease. Futura, mount kisco N.Y. pp 99–151, 1985.Google Scholar
  58. 57.
    Martin RP, Bowden R, Filly K, Popp RL: Intrapericardial abnormalities in patients with pericardial effusion. Findings by two dimensional echocardiography. Circulation 61: 568572, 1980.Google Scholar
  59. 58.
    Burstow DJ, Oh JK, Bailey KR, et al.: Cardiac tamponade: characteristic Doppler observations. Mayo Clin Proc 64: 31 2324, 1989.Google Scholar
  60. 59.
    Fowler NO: Cardiac tamponade: a clinical or an echocardiographic diagnosis? Circulation 87: 1738–1741, 1993.PubMedCrossRefGoogle Scholar
  61. 60.
    Klopfenstein HS, Schuchard GH, Wann LS, Palmer TE, Hartz AJ, Gross CM, et al.: The relative merits of pulsus parodoxus and right ventricular diastolic collapse in the early detection of cardiac tamponade: an experimental echocardiographic study. Circulation 71: 829–833, 1985.PubMedCrossRefGoogle Scholar
  62. 61.
    Spodick DH: The electrocardiogram in acute pericarditis: distributions of morphologic and axial changes by stage. Am J Cardiol 33: 470–474, 1974.PubMedCrossRefGoogle Scholar
  63. 62.
    Singhal MJ, Jha R, Agarwal SK, et al.: Uremic pericarditis—prevention of complications. J Nephrol 8: 113–117, 1995.Google Scholar
  64. 63.
    Sanders PW, Taylor Z, Curtis JJ: Hemodialysis without anticoagulation. Am J Kidney Dis 5: 32–35, 1985.PubMedGoogle Scholar
  65. 64.
    Von Brecht JH, Flanigan MY, Freeman RM, Lim VS: Regional anticoagulation: hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis 8: 196–201, 1986.Google Scholar
  66. 65.
    Luft FC, Gilman JK, Weyman DE: Pericarditis in the patient with uremia: clinical and echocardiographic evaluation. Nephron 25: 160–166, 1980.PubMedCrossRefGoogle Scholar
  67. 66.
    Buselmeier TJ, Simmons RL, Najarian JS, Mauer SM, Matas AJ, Kjellstrand CM: Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron 16: 271–280, 1976.Google Scholar
  68. 67.
    Fuller TJ, Knochel JP, Brennan JP, Fetner CD, White MG: Reversal of intractable uremic pericarditis by triamcinolone hexacetonide. Arch Intern Med 136: 979–982, 1976.PubMedCrossRefGoogle Scholar
  69. 68.
    Connors JP, Kleiger RE, Shaw RC, et al.: The indication for pericardiectomy in the uremic pericardial effusion. Surgery 80: 689–694, 1976.PubMedGoogle Scholar
  70. 69.
    Ghavamin M, Gutch CF, Hughes RK, et al.: Pericardial tamponade in chronic hemodialysis patients. Treatment by pericardiectomy. Arch Intern Med 131: 249–253, 1973.CrossRefGoogle Scholar
  71. 70.
    Gafter U, Chachkes M, Zevin D, Levi J: Therapeutic approach to pericarditis in uremia. Isr J Med Sci 26: 107–109, 1990.PubMedGoogle Scholar
  72. 71.
    Morin JE, Mulder DS, Long R: Pericardiectomy for uremic tamponade. Can J Surg 19: 109–112, 1976.PubMedGoogle Scholar
  73. 72.
    Shabetai R: Pericardial disease: etiology, pathophysiology, clinical recognition and treatment. In: JT Willerson, JN Cohn, eds, Cardiovascular Medicine. Churchill Livingston, New York, pp 1011–1040, 1995.Google Scholar
  74. 73.
    Feinroth MV, Goldstein EJC, Josephson A, Friedman EA: Infection complicating intrapericardial steroid instillation in uremic pericarditis. Clin Nephrol 15: 331–333, 1981.PubMedGoogle Scholar
  75. 74.
    Minuth ANW, Nottebohm GA, Eknoyan G, Suki WN: Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med 135: 807–810, 1975.PubMedCrossRefGoogle Scholar
  76. 75.
    Spector D, Alfred H, Siedlecki M, Briefel G: A controlled study of the effect of indomethacin in uremic pericarditis. Kidney Int 24: 663–669, 1983.PubMedCrossRefGoogle Scholar
  77. 76.
    Miller JI: Surgical management of pericardial disease. In: RC Schlant, W Alexander, eds, Hurst’s The Heart Arteries and Veins,8th ed, pp 1675–1680, 1994. Mc Graw-Hill N.Y.Google Scholar
  78. 77.
    Nataf P, Cacoub P, Dorent R, Jault F, Pavie A, Cabrol C, Gandjbakhch I: Results of subtotal pericardiotomy for constrictive pericarditis. Eur J Cardiothorac Surg 7: 252–256, 1993.PubMedCrossRefGoogle Scholar
  79. 78.
    Gorlin R, Hoseupud JD, Greenberg BH: Evolution of concepts of myocardial function in the treatment of congestive heart failure. In: JD Hoseupud, 13H Greenberg, eds, Congestive Heart Failure. N. York Springer-Verlag, pp 3–8, 1994.Google Scholar
  80. 79.
    Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients. Prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884–890, 1995.PubMedCrossRefGoogle Scholar
  81. 80.
    Cruz IA, Bhatt GR, Cohen HC, et al.: Echocardiographic detection of cardiac involvement in patients with chronic renal failure. Arch Intern Med 138: 720–724, 1978.PubMedCrossRefGoogle Scholar
  82. 81.
    Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre PE: Congestive heart failure in dialysis patients. Arch Intern Med 148: 1519–1525, 1988.PubMedCrossRefGoogle Scholar
  83. 82.
    Lai KN, Ng J, Whitford J, Buttfield I, Fassett RG, Mathew TH: Left ventricular function in uremia: echocardiographic and radionuclide assessment in patients on maintenance hemodialysis. Clin Nephrol 23: 125–133, 1985.PubMedGoogle Scholar
  84. 83.
    Wizemann V, Kramer W, Thormann J, Kindler M: Exercise-induced ventricular dysfunction: reversible by hemodialysis. Trans Am Soc Artif Intern Organs 30: 567–570, 1984.PubMedGoogle Scholar
  85. 84.
    Chaignon M, Chen WT, Tarazi RC, Bravo EL, Nakamato S: Effect of hemodialysis on blood volume distribution and cardiac output. Hypertension 3: 327–332, 1981.PubMedCrossRefGoogle Scholar
  86. 85.
    Nixon JV, Mitchell JH, McPhaul JJ, Henrich WL: Effect of hemodialysis on left ventricular function. J Clin Invest 71: 377–384, 1983.PubMedCrossRefGoogle Scholar
  87. 86.
    Kim KE, Onesti G, Del Guercio ET, et al.: Sequential hemodynamic changes in end-stage renal disease and the anephric state during volume expansion. Hypertension 2: 102–110, 1980.PubMedCrossRefGoogle Scholar
  88. 87.
    Vincenti F, Amend JW, Abele J, et al.: The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 68: 363–369, 1980.PubMedCrossRefGoogle Scholar
  89. 88.
    Rostand SG, Kirk KA, Rutsky EA: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22: 304–308, 1982.PubMedCrossRefGoogle Scholar
  90. 89.
    Ahearm DH, Maher JF: Heart failure as a complication of a hemodialysis arteriovenous fistula. Ann Intern Med 77: 20 1204, 1972.Google Scholar
  91. 90.
    Timmis AD, Mc Gonigle RJ, Weston MJ, Mc Leod AA, Jackson G, Jewitt DE, Parsons V: The influence of hemodialysis fistulas on circulatory dynamics and left ventricular function. Int J Artif Organs 5: 101–104, 1982.PubMedGoogle Scholar
  92. 91.
    Payne RM, Sodeblom RE, Lobstein PH, et al.: Exercise-induced hemodynamic effects of arterio-venous fistulas used for hemodialysis. Kidney Int 2: 344–348, 1972.PubMedCrossRefGoogle Scholar
  93. 92.
    Cohn SJ, Chandraratna PAN, Winer RL, Shah GM, Aronow WS: Echocardiographic assessment of the hemodynamic effects of arteriovenous fistulas in patients with chronic renal failure. J Cardiovasc Ultrasonogr 2: 5, 1983.Google Scholar
  94. 93.
    Silberberg JS, Rahel DP, Patton DR, et al.: Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 64: 222–224, 1989.PubMedCrossRefGoogle Scholar
  95. 94.
    Fellner SK, Lang RM, Neuman A, Korcarz C, Borow KM: Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int 14: 1309–1315, 1993.CrossRefGoogle Scholar
  96. 95.
    Sikole A, Polenakovic M, Spirovska V, Polenakovic B, Masin G: Analysis of heart morphology and function following erythropoietin treatment of anemic dialysis patients. Artif Organs 17: 977–984, 1993.PubMedCrossRefGoogle Scholar
  97. 96.
    Terman DS, Alfrey AC, Hammond WS, et al.: Cardiac calcification in uremia. A clinical, biochemical and pathologic study. Am J Med 50: 744, 1971.PubMedCrossRefGoogle Scholar
  98. 97.
    Rostand SG, Sanders C, Kirk KA, Rustky EA, Fraser RG: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85: 651–657, 1988PubMedCrossRefGoogle Scholar
  99. 98.
    Abrahams C, D’Cruz I, Kathpalia S: Anormalities in the mitral valve apparatus in patients undergoing long-term hemodialysis. Autopsy and echocardiographic correlation. Arch Intern Med 142: 1796–1800, 1982.PubMedCrossRefGoogle Scholar
  100. 99.
    Nestico PF, DePace NL, Kotler MN, et al.: Calcium phosphorus metabolism in dialysis patients with and without mitral anular calcium. Analysis of 30 patients. Am J Cardiol 51:497— 500, 1983.Google Scholar
  101. 100.
    Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR: Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2: 875–877, 1987.PubMedCrossRefGoogle Scholar
  102. 101.
    Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR: Aortic and mitral valve disease in patients with end stage renal failure on long term haemodialysis. Br Heart J 67: 236239, 1992.Google Scholar
  103. 102.
    Khoss AE, Steger H, Legenstein E, Proll E, Salzer-Muhar M, Schlemmer M, Balzar E, Wimmer M: L-carnitine therapy and myocardial function in children treated with chronic hemodialysis. Wien Klin Wochenschr 101: 17–20, 1989.PubMedGoogle Scholar
  104. 103.
    Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286–290, 1989.PubMedCrossRefGoogle Scholar
  105. 104.
    Alpert MA, Wizeman V, Huting J, Massey CV: Nominvassive assessment of left ventricular structure and function in patients with end-stage renal disease. In: M Timino, V Wizemann, eds, Contribution to Nephrology, vol 106. S Karger, AG Basel, pp 13–25, 1994.Google Scholar
  106. 105.
    Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J III, Feinleib M, Castelli WP: The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 75 (Suppl 1):I-26—I-33, 1987.Google Scholar
  107. 106.
    Huwez FV, Pringle SD, Macfarlane PW: A new classification on left ventricular geometry in patients with cardiac disease based on M-mode echocardiography. Am J Cardiol 70: 68 1688, 1992.Google Scholar
  108. 107.
    Devereux RB, Pickering TG, Alderman MH, et al.: Left ventricular hypertrophy in hypertension: prevalence and relation to pathophysiologie variables. Hypertension 9: 1153 1160, 1987.Google Scholar
  109. 108.
    Hammond IN, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH: The prevalence and correlation of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Med Coll Cardiol 7: 639–650, 1986.CrossRefGoogle Scholar
  110. 109.
    Cohen MV, Diaz P, Scheuer J: Echocardiographic assessment of left ventricular function in patients with chronic uremia. Clin Nephrol 12: 156–162, 1979.PubMedGoogle Scholar
  111. 110.
    Ikram H, Lynn KL, Bailey RR, Little PJ: Carvascular changes in chronic hemodialysis patients. Kidney Int 24: 37 1376, 1983.Google Scholar
  112. 111.
    Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, Guttman RD: Left ventricular hypertrophy in end stage renal disease. Nephron 48: 107–115, 1988.PubMedCrossRefGoogle Scholar
  113. 112.
    London GM, de Vernejoul MC, Fabiani F, et al.: Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32: 900–907, 1987.PubMedCrossRefGoogle Scholar
  114. 113.
    Parfrey PS, Harnett JD: Long-term cardiac morbidity and mortality during dialysis therapy. Adv Nephrol Necker Hosp 23: 311–330, 1994.PubMedGoogle Scholar
  115. 114.
    Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186–192, 1995.PubMedCrossRefGoogle Scholar
  116. 115.
    Hung J, Harris PJ, Uren RF et al.: Uremic cardiomyopathyeffect of hemodialysis on left ventricular function in end stage renal failure. N Engl J Med 302: 547–557, 1980.PubMedCrossRefGoogle Scholar
  117. 116.
    Madsen BR, Alpert MA, Whiting RB, Van Stone J, Ahmad M, Kelly DL: Effect of hemodialysis on left ventricular performance. Am J Nephrol 4: 86–91, 1984.PubMedCrossRefGoogle Scholar
  118. 117.
    Chaignon M, Chen WT, Tarazi RC, Nakamoto S, Salcedo: Acute effects of hemodialysis on echographic-determined cardiac performance: improved contractility resulting from serum-increased calcium with reduced potassium despite hypovolemic-reduced cardiac output. Am Heart J 103: 374378, 1982.Google Scholar
  119. 118.
    Henrich WL, Hung J, Nixon JV: Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med 310, 1984.Google Scholar
  120. 119.
    Ruder MA, Alpert MA, Van Stone J et al.: Comparative effects of acetate and bicarbonate hemodialysis on left ventricular function. Kidney Int 27: 768–773, 1985.PubMedCrossRefGoogle Scholar
  121. 120.
    Huting J, Kramer W, Schutterle, Wizemann V: Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron 49: 284–290, 1989.Google Scholar
  122. 121.
    Rottenbourg JB: CAPD is more advantageous than hemodialysis. Semin Dial 5: 212–214, 1992.CrossRefGoogle Scholar
  123. 122.
    Alpert MA, Van Stone J, Twardowski ZJ, Nolph KD: Comparative cardiac effects of hemodialysis and continuous ambulatory pertoneal dialysis. Clin Cardiol 9: 52–58, 1986.PubMedCrossRefGoogle Scholar
  124. 123.
    Tabacchi GC, Castiglioni A, Giongranole A, et al.: Echo-cardiographic evaluation of left ventricular function in patients in CAPD. Peritoneal Dial Bull 7: 578–581, 1987.Google Scholar
  125. 124.
    Franklin JA, Alpert MA, Twardowski ZJ: Effect of increasing intrabdominal pressure and volume on left ventricular function in CAPD. Am J Kidney Dis 12: 291–298, 1988.PubMedGoogle Scholar
  126. 125.
    Low I, Grutzmacher P, Bergmann M, Schoeppe W: Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin. Clin Nephrol 31: 26–30, 1989.PubMedGoogle Scholar
  127. 126.
    Low-Friedrich I, Grutzmacher P, Marz W, Bergmann M, Schoeppe W: Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients. Am J Nephrol 11: 54–60, 1991.PubMedCrossRefGoogle Scholar
  128. 127.
    Paganini EP, Fouad FM, Tarazi RC: Systemic hypertension in chronic renal failure. In: RA O’Rourke, BM Brenner, JH Stein, eds, The Heart and Renal Disease. Churchill Livingstone, New York, p 127, 1984.Google Scholar
  129. 128.
    Stablen DM, Hamburger RJ, Lindgloid AS, Nolph KD, Novak JW: The effect of CAPD on hypertension control: a report of the national CAPD registry. Peritoneal Dial Int 8: 141–144, 1988.Google Scholar
  130. 129.
    Roy LF, Leehen FHH: Therapy of hypertension in end-stage renal disease. In: P Parfrey, JD Harnett, eds, Cardiac Dysfunction in Chronic Uremia. Kluwer Academic Publishers, Boston, pp 245–266, 1992.Google Scholar
  131. 130.
    Dahlof B, Pennert K, Hansson L: Reversal of LVH in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 5: 95–110, 1992.PubMedGoogle Scholar
  132. 131.
    The CONSENSUS Trial Study Group: Effect of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435, 1987.CrossRefGoogle Scholar
  133. 132.
    The SOLVD Inestigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fraction on congestive heart failure. N Engl J Med 325: 293–302, 1991.CrossRefGoogle Scholar
  134. 133.
    The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 325: 303–310, 1991.CrossRefGoogle Scholar
  135. 134.
    Cohn JN, Johnson G, Ziesche S, et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303–310, 1991.PubMedCrossRefGoogle Scholar
  136. 135.
    Greenber BH: The medical managment of chronic congestive heart failure. In: JD Hosenpud, BH Greenberg, eds, Congestive Heart Failure: Pathophysiology, Diagnosis and Comprehensive Approach to Management. Springer-Verlag, New York, pp 628–644, 1994.Google Scholar
  137. 136.
    Packer M, Gheorghiade M, Young JB, Constantin PJ, Adams KF, Cody RI, Smith LK, Van Voorhees L, Gourely LA, Jolly MK, for the RADIANCE Study: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE study. N Engl J Med 329: 1–7, 1993.PubMedCrossRefGoogle Scholar
  138. 137.
    Uretsky BF, Young JB, Shahidi FD, Yellen LG, Harrison MC, Jolly MK, on behalf of the PROVED Investigative Group: Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 22: 955–962, 1993.PubMedCrossRefGoogle Scholar
  139. 138.
    Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MD, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group: Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342: 1441–2446, 1993.PubMedCrossRefGoogle Scholar
  140. 139.
    Ferrari R: Calcium antagonists and left ventricular dysfunction. Am J Cardiol 75: 71E - 76E, 1995.PubMedCrossRefGoogle Scholar
  141. 140.
    Verresen L, Waer M, Vanrenterghem Y, Michielsen P: Angiotensin converting-enzyme inhibitors and anphilactoid reactions to high-flux membranes. Lancet 336: 1360–1362, 1990.PubMedCrossRefGoogle Scholar
  142. 141.
    Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR: Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 42: 1232–1237, 1992.PubMedCrossRefGoogle Scholar
  143. 142.
    Verrsen L, Fink E, Lenske H-D, Vanrenterghem Y: Bradykinin is a mediator of anphylactoid reactions during hemodialysis with AN 69 membranes. Kidney Int 45: 1497–1503, 1994.CrossRefGoogle Scholar
  144. 143.
    Hara S, Ubara Y, Arizono K, Ikeguchi H, Katori H, Yamada A, Ogura Y, Murata H, Mimura N: Relation between parathyroid hormone and cardiac function in long-term 838 Therapy of Renal Diseases & Related Disorders hemodialysis patients. Miner Electrolyte Metab 21: 72–76, 1995.PubMedGoogle Scholar
  145. 144.
    McGonigle RJS, Fowler MB, Timmis AB, Weston MJ, Parsons V: Uremic cardiomyopathy: potential role of parathyroid hormone. Nephron 36: 94–100, 1984.PubMedCrossRefGoogle Scholar
  146. 145.
    Burt RK, Gupta-Burk S, Suki WN, et al.: Reversal of left ventricular dysfunction after kidney transplantation. Ann Intern Med 111: 635–640, 1989.PubMedCrossRefGoogle Scholar
  147. 146.
    Cueto-Garcia L, Herrera J, Arriaga J, Laredo C, Meaney E: Echocardiographic changes after successful renal transplantation in young nondiabetic patients. Chest 83: 56–62, 1983.PubMedCrossRefGoogle Scholar
  148. 147.
    Larsson O, Attman PO, Beckman-Suurkula M, Wallentin I, Wikstrand J: Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus. Eur Heart J 7: 779–791, 1986.PubMedGoogle Scholar
  149. 148.
    Huting J: Course of left ventricular hypertrophy and function in end-stage renal disease after transplantation. Am J Cardiol 70: 1481–1484, 1992.PubMedCrossRefGoogle Scholar
  150. 149.
    Smogorzewski M: Renal transplantation in specific disease. In: SG Massry, RJ Glassock, eds, Massry’s and Glassock Textbook of Nephrology. Williams & Wilkins, Baltimore, pp 1707–1717, 1994.Google Scholar
  151. 150.
    Amann K, Wiest G, Zimmer G, Gretz N, Ritz F, Mall G: Reduced capillary density in the myocardium of uremic rats-a stereological study. Kidney Int 42: 1079–1085, 1992.PubMedCrossRefGoogle Scholar
  152. 151.
    Rostand SG, Kirk KA, Rutsky EA: The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. Contrib Nephrol 52: 34–41, 1985.Google Scholar
  153. 152.
    Simon P, Autuly V, Ang KS, et al.: Epidemiologic data on ischemic heart disease (IHD) in a dialyzed population (abstract). J Am Soc Nephrol 3: 395, 1992.Google Scholar
  154. 153.
    Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: Insights from coronary antiography. Kidney Int 25: 653–659, 1984.PubMedCrossRefGoogle Scholar
  155. 154.
    Rostand SG, Rutsky EA: Coronary artery disease in end-stage renal disease. In: WL Henrich ed, Principles and Practice of Dialysis. Williams & Wilkins, Baltimore, pp 181–195, 1994.Google Scholar
  156. 155.
    Rostand SG, Kirk KA, Rutsky EA: Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22: 304–308, 1982.PubMedCrossRefGoogle Scholar
  157. 156.
    Holley JL, Fenton RA, Arthur RS: Thallium stress testing does not predict cardovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 90: 503–570, 1991.Google Scholar
  158. 157.
    Brown JH, Vites NP, Testa HH, Prescott MC, Hunt LP, Gokol R, Mallick NP: Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 8: 433437, 1993.Google Scholar
  159. 158.
    Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Wernes SW, Armstrong WF: Usefuness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 75: 707–710, 1995.PubMedCrossRefGoogle Scholar
  160. 159.
    Goldberg AP, Hagberg JM, Delmez JA, et al.: Metabolic effects of exercise training in hemodialysis patients. Kidney Int 18: 754–761, 1980.PubMedCrossRefGoogle Scholar
  161. 160.
    Grundy SM: Management of hyperlipdemia of kidney disease. Kidney Int 37: 847–853, 1990.PubMedCrossRefGoogle Scholar
  162. 161.
    Boudaulas H: Cardiovascular drug therapy in patients with renal disease. In: CV Leier, H Boudoulas, eds, Cardiorenal Disorders and Diseases. Futura, Mount Kisco, NY, pp 275315, 1992.Google Scholar
  163. 162.
    Rinehart AL, Herzog CA, Collins AJ, Fack JM, Jennie Z, Ma MS, Opsahl JA: A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 25: 281–290, 1995.PubMedCrossRefGoogle Scholar
  164. 163.
    Rostand SG, Kirk KA, Rutsky EA, Pacifico AD: Results of coronary artery bypass grafing in end-stage renal disease. Am J Kidney Dis 12: 266–270, 1988.PubMedGoogle Scholar
  165. 164.
    Batiuk T, Kurtz SB, Oh JK, Orszulak TA: Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 66: 4553, 1991.CrossRefGoogle Scholar
  166. 165.
    Kahn JK, Rutherford BD, McConahay DR, et al.: Short-and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 119: 484489, 1990.Google Scholar
  167. 166.
    Deutsch E, Bernstein RC, Addonizio P, Kussmaul WG III: Coronary artery bypass surgery in patients on chronic hemodialysis. Ann Intern Med 110: 369–372, 1989.PubMedCrossRefGoogle Scholar
  168. 167.
    Ahmed WH, Shubrooks SJ, Gibson MC, Bain DS, Bittl JA: Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 128: 252–255, 1994.PubMedCrossRefGoogle Scholar
  169. 168.
    Wizemann V, Kramer W, Thormann J, Kindler M, Schutterle G: Cardiac arrhythmias in patients on maintenance hemodialysis: causes and management. Contrib Nephrol 52: 42–53, 1986.PubMedGoogle Scholar
  170. 169.
    Kimura K, Tabei K, Asano Y, Hosoda S: Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephrol 53: 201–207, 1989.Google Scholar
  171. 170.
    Redaelli B, Cavalli A, Catini R, et al.: (Gruppo emodialisi e patologie cardiovasculari): Multicentre, cross-sectional study of ventricular arrhythmias in chronically hemodialyzed patients. Lancet 2: 305–308, 1988.Google Scholar
  172. 171.
    Wizemann V, Kramer W: Cardiac arrhythmias in end-stage renal disease: prevalence, risk factors, and management. In: PS Parfrey, JD Harnett, eds, Cardiac Dysfunction in Chronic Uremia. Kluwer Academic Publishers, Boston, pp 67–81, 1992.CrossRefGoogle Scholar
  173. 172.
    Niwa A, Taniguchi K, Ito H, Nakagawa S, Takeuchi J, Sasaoka T, Kanayama M: Echocardiographic and Hotter findings in 321 uremic patients on maintenance hemodialysis. Jpn Heart J 26: 403–411, 1985.PubMedCrossRefGoogle Scholar
  174. 173.
    D’Elia J, Weinrauch L, Gleason R, et al.: Application of the ambulatory 24-hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med 148: 2381 2385, 1988.Google Scholar
  175. 174.
    Sforzini S, Latini R, Mingadi G, Vincent A, Redaelli B: Ventricular arrhythmias and four-year mortality in hemodialysis patients. Gruppo Ernodialisi e Patologie Cardiovasculari. Lancet 339: 212–213, 1992.PubMedCrossRefGoogle Scholar
  176. 175.
    Rutsky EA: Arrhythmias in hemodialysis patients. In: AR Nissenson, RN Fine, eds, Dialysis Therapy, 2nd ed. Hanley and Belfus, Philadelphia, pp 116–123, 1992.Google Scholar
  177. 176.
    Abuelo JG, Shemin D, Chazan JA: Acute symptoms produced by hemodialysis: a review of their causes and association. Semin Dial 6: 59–69, 1993.CrossRefGoogle Scholar
  178. 177.
    Victor RG, Henrich WL: Autonomic neuropathy and hemodynamic stability in end-stage renal disease patients. In: WL Henrich, ed, Principles and Practice of Dialysis. Williams & Wilkins, Baltimore, pp 196–208, 1994.Google Scholar
  179. 178.
    Converse RL, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-Tarazi F, Victor RG: Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 90: 1657–1665, 1992.PubMedCrossRefGoogle Scholar
  180. 179.
    Lilley JJ, Golden J, Stone RA: Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 57: 1190 1200, 1976.Google Scholar
  181. 180.
    Campese VM, Romoff MS, Levitan D, Lane K, Massry SG: Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 20: 246–253, 1981.PubMedCrossRefGoogle Scholar
  182. 181.
    Velez RL, Woodard TD, Henrich WL: Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction. Kidney Int 26: 59–65, 1984.PubMedCrossRefGoogle Scholar
  183. 182.
    Schilling Lehman H, Hampl H: Studies on circulatory stability during bicarbonate hemodialysis with constant dialysate sodium versus acetate hemodialysis with sequential dialysate sodium. Artif Organs 9: 17–21, 1985.CrossRefGoogle Scholar
  184. 183.
    Levy FL, Grayburn PA, Foulks CJ, Brickner ME, Henrich WL: Improved left ventricular contractility with cool temperature hemodialysis. Kidney Int 41: 961–965, 1992.PubMedCrossRefGoogle Scholar
  185. 184.
    Jost CM, Agarwal R, Khair-el-Din T, Graybourn PA, Victor RG, Henrich WL: Effect of cooler temperature dialysate on hemodynamic stability in “problem” dialysis patients. Kidney Int 44: 606–612, 1993.PubMedCrossRefGoogle Scholar
  186. 185.
    Maggiore Q, Pizzarelli F, Sisca S, Zocalli C, Parlongo S, Nicolo F, Creazzo G: Blood temperature and vascular stability during hemodialysis and hemofiltration. Trans Am Soc Artif Intern Organs 28: 523–527, 1982.PubMedGoogle Scholar
  187. 186.
    Sherman RA, Faustino EF, Bernholc AS, Eisinger RP: Effect in variations in dialysate temperature on blood pressure during hemodialysis. Am J Kidney Dis 4: 66–68, 1984.PubMedGoogle Scholar
  188. 187.
    Cross AS, Steigbigel RT: Infective endocarditis and access site infections in patients on hemodialysis. Medicine (Baltimore) 55: 453–466, 1976.Google Scholar
  189. 188.
    Nichols A, Edward N, Cutto G: Staphylococcal septicemia, endocarditis and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J 56: 642–648, 1980.CrossRefGoogle Scholar
  190. 189.
    Leonard A, Roy L, Shapiro FL: Bacterial endocarditis in regularly dialyzed patients. Kidney Int 4: 407–422, 1973.PubMedCrossRefGoogle Scholar
  191. 190.
    Birkeland SA: Uremia as a state of immune deficinecy. Scand J Immunol 5: 107–1115, 1976.PubMedCrossRefGoogle Scholar
  192. 191.
    Descamps-Latscha B, Herbelin L: Long-term dialysis and cellular immunity: a critical survey. Kidney Int 43 (Suppl 4): S135 — S142, 1993.CrossRefGoogle Scholar
  193. 192.
    Ruiz P, Gomez F, Schreiber AD: Impaired function macrophage F, gamma receptors in end-stage renal disease. N Engl J Med 322: 717–722, 1990.PubMedCrossRefGoogle Scholar
  194. 193.
    Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG: Impaired phagocytosis in dialysis patients. Studies on mechanisms. Am J Nephrol 11: 102–111, 1992.CrossRefGoogle Scholar
  195. 194.
    Albers FJ: Causes of hemodialysis access failure. Adv Renal Replacement Ther 1: 107–118, 1994.Google Scholar
  196. 195.
    Swartz RD, Messana JM, Boyer CJ, Lunde NM, Weitzel WF, Hartman TL: Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol 4: 1719–1725, 1994.PubMedGoogle Scholar
  197. 196.
    Brecia MJ, Cimino JE, Appel K, Hurwitz BJ: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275: 1089–1092, 1966.CrossRefGoogle Scholar
  198. 197.
    Scheid WM, Sande MA: Endocarditis and intravascular infections. In: GL Mandell, JE Bennett, R Dolin, eds, Mandell, Douglas and Bennett’s Principles of Infectious Diseases. Churchill Livingstone, New York, pp 740–783, 1995.Google Scholar
  199. 198.
    Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echo-cardiographic findings. Am J Med 96: 200–203, 1994.PubMedCrossRefGoogle Scholar
  200. 199.
    Von Reyn CF, Levy BS, Arbeit RD, Friedlander G, Crumpacker CS: Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 94: 505–517, 1981.CrossRefGoogle Scholar
  201. 200.
    Stewart WJ, Shank: The diagnosis of prosthetic valve endocarditis by echocardiography. Semin Thorac Cardiovasc Surg 7: 7–12, 1995.PubMedGoogle Scholar
  202. 201.
    Dajan AS, Bisno AL, Chung KJ, et al.: Prevention of bacterial endocarditis: recommendations of the American Heart Association. JAMA 264: 2919–2922, 1992.Google Scholar
  203. 202.
    Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ: Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 315: 9196, 1986.CrossRefGoogle Scholar
  204. 203.
    Chow JW, Yu VL: Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Arch Intern Med 49: 1258–1262, 1989.CrossRefGoogle Scholar
  205. 204.
    Padberg FT Jr, Lee BC, Curl GR: Hemoaccess site infection. Surg Gynecol Obstet 174: 103–108, 1992.PubMedGoogle Scholar
  206. 205.
    Durack DT: Infective endocarditis. In: PD Hoeprich, MC Jordan, AR Ronald, eds, Infectious Diseases. JB Lippincott, Philadelphia, pp 1233–1248, 1994.Google Scholar
  207. 206.
    Bisno AL, Dismukes WE, Durack DT, et al.: Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci and staphylococci. JAMA 261: 1471–1477, 1989.PubMedCrossRefGoogle Scholar
  208. 207.
    Kaul TK, Fields BL, Reddy MA, Kahn DR: Cardiac operations in patients with end-stage renal disease. Ann Thorac Surg 57: 691–696, 1994.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Miroslaw Smogorzewski
    • 1
  1. 1.Division of NephrologyUniversity of Southern California School of MedicineLos AngelesUSA

Personalised recommendations